Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 28 February 2008. doi:10.1136/ard.2007.082495
Annals of the Rheumatic Diseases 2009;68:94-98
Copyright © 2009 BMJ Publishing Group Ltd & European League Against Rheumatism.

CLINICAL AND EPIDEMIOLOGICAL RESEARCH

Autologous stem cell transplantation improves microcirculation in systemic sclerosis

I Miniati1, S Guiducci1, M L Conforti1, V Rogai1, G Fiori1, M Cinelli1, R Saccardi2, S Guidi2, A Bosi2, A Tyndall3, M Matucci-Cerinic1

1 Department of Biomedicine, Division of Rheumatology, DENOthe Center, AOUC, Florence, Italy
2 Bone Marrow Transplantation Unit, AOUC, Florence, Italy
3 Department of Rheumatology, University of Basel, Basel, Switzerland

I Miniati, Department of Biomedicine, Section of Rheumatology, DENOthe Center, AOUC Florence, Viale Pieraccini 18, 50139 Florence, Italy; irene.miniati{at}unifi.it

Background: In systemic sclerosis (SSc) reduced capillary density decreases blood flow and leads to tissue ischaemia and fingertip ulcers. Nail fold videocapillaroscopy (NVC) is a diagnostic and follow-up parameter useful to evaluate the severity, activity and the stage of SSc microvascular damage. Autologous haemopoietic stem cell transplantation (HSCT) is a new treatment for patients with severe diffuse cutaneous systemic sclerosis (dcSSc) refractory to conventional therapies. We aimed to evaluate the improvement of microvasculature after HSCT using NVC.

Methods: A total of 16 patients with severe dcSSc with a "late" videocapillaroscopy pattern underwent an immunesuppressive treatment: 6 were treated with HSCT and 10 with monthly pulse cyclophosphamide (CYC) 1 g for 6 months and then orally with 50 mg/day for further 6 months.

NVC was performed before and after 3 months from the beginning of each treatment and then repeated every 3 months.

Results: In all patients, before HSCT NVC showed large avascular areas and ramified capillaries and vascular architectural disorganisation ("late" pattern). At 3 months after HSCT, the NVC pattern changed from "late" into "active", showing frequent giant capillaries (>6/mm) and haemorrhages, absence of avascular areas and angiogenesis phenomena; 1 year after HSCT, microvascular abnormalities were still in the "active" pattern. In patients treated with CYC, no NVC modifications were observed during 24 months of follow-up and the pattern always remained "late".

Conclusions: These results indicate that HSCT with a high dose CYC regimen may foster vascular remodelling, while CYC at lower doses and with a chronic regimen does not influence the microvasculature.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs